Statins

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
15:20

Houston Methodist DeBakey Heart and Vascular Center

Risk Stratification and CV Prevention: When Is CT Calcium Score Indicated? CAC Testing as Decision Aid

FEATURING Khurram Nasir
  • 788 views
  • March 23, 2021
  • 6
21:16

ASPC 2020 Virtual Summit on CVD Prevention

ASPC Expert Discussion on Biologics Usage for CV Risk Reduction, Efficacy of Polypharmacy, Statin Usage in Elderly, Ischemia Trial, BP Intensity Control, and Optimal Medical Therapy Approach

FEATURING Christie Ballantyne, Ann Marie Navar, David Maron, Keith Ferdinand, Paul Ridker
  • 37 views
  • March 17, 2021
14:55

ASPC 2020 Virtual Summit on CVD Prevention

Statin Usage in Athletes: Is There Increased Muscle Injury With Statins Usage? Can They Reduce Exercise Training Response? What Are the Administration Recommendations?

FEATURING Paul D. Thompson
  • 22 views
  • March 12, 2021
27:36

ASPC 2020 Virtual Summit on CVD Prevention

Sex Differences in Atherosclerosis: Is There a Sex Specific Phenotype for Atherosclerotic Plaque? Can Antiplatelet Therapy & Statins Improve CVD Outcomes?

FEATURING Leslee Shaw
  • 29 views
  • March 12, 2021
16:05

ASPC 2020 Virtual Summit on CVD Prevention

Polypill for CVD Prevention: When Is Polypharmacy Appropriate? Can Rosuvastatin + Candesartan + HCTZ Reduce CV Events?

FEATURING Keith Ferdinand
  • 164 views
  • March 12, 2021
  • 1
18:02

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?

FEATURING Pam Taub
  • 925 views
  • February 5, 2021
  • 11
39:29

37th Annual Advances in Heart Disease

Contemporary Approach for Managing PAD: What Are the Guideline Recommended Therapies? What Is the Efficacy of Statin Therapy, PCSK9 Inhibitors, Antiplatelet Agents and Anticoagulants?

FEATURING Mark Creager, Binh An Phan
  • 259 views
  • February 4, 2021
  • 2
22:01

University of Colorado Department of Medicine

NAFLD Epidemiology & Diagnosis: When to Screen? What Are the Indications for Transplantation? Is Statin Therapy Safe for NAFLD/NASH?

FEATURING Amanda Wieland
  • 81 views
  • February 2, 2021
08:30

University of Colorado Department of Medicine

NAFLD Pharmacologic Management: What Are the Benefits & Safety Concerns of Vitamin E and Pioglitazone? What Is the Efficacy of OCA?

FEATURING Amanda Wieland
  • 126 views
  • February 2, 2021
35:46

37th Annual Advances in Heart Disease

Lipoprotein(a) and CVD: Do Elevated Lp(a) Levels Contribute to CVD Risk? What Are the Effects of Statins, PCSK9-i, LDL Apheresis and ASOs Therapies?

FEATURING Binh An Phan, Peter Ganz
  • 1,823 views
  • January 29, 2021
  • 16
19:46

Cardiometabolic Health Congress (CMHC)

ASCVD Risk Reduction Recommendations: Who Benefits From High Intensity Statins? Which Non-Statin Therapies to Choose? What Is the Efficacy of Inclisiran in Patients With Elevated LDL Cholesterol?

FEATURING Margo Minissian
  • 165 views
  • January 18, 2021
  • 1
17:57

Cardiometabolic Health Congress (CMHC)

CMHC Tsunami Expert Discussion on Nutrition, Insulin Therapy, Practical Tips for Telemedicine, and the Link Between Hyperinsulinemia & Atherosclerosis

FEATURING Margo Minissian, Robert Eckel, Keith Ferdinand
  • 60 views
  • January 15, 2021
24:35

Keck School of Medicine of USC

Role of Lipoprotein(a) in Coronary Disease: What CV Risks Can you Expect? How to Manage the Condition?

FEATURING Steven Nissen
  • 947 views
  • January 5, 2021
  • 13
15:21

26th Annual San Diego Heart Failure Symposium

Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?

FEATURING Pam Taub
  • 974 views
  • December 15, 2020
  • 9
19:34

Cardiometabolic Health Congress (CMHC)

Q&A on Novel Therapies and Approaches in LDL-C Reduction

FEATURING Salim Virani, Christie Ballantyne, Pam Taub
  • 605 views
  • September 22, 2020
15:14

Cardiometabolic Health Congress (CMHC)

55 y/o Female With Hypertension, Hypothyroidism, and Metabolic Syndrome: How to Optimize LDL-C Reduction Therapy?

FEATURING Salim Virani, Christie Ballantyne, Pam Taub
  • 442 views
  • September 22, 2020
  • 2
19:24

Cardiometabolic Health Congress (CMHC)

2020 Update on LDL-C Reduction: Does Aggressive LDL-C Lowering Therapy Eliminates CVD Risk? What Are the Benefits of LDL Lowering on Plaque Regression?

FEATURING Pam Taub
  • 903 views
  • September 22, 2020
  • 9
09:03

Cardiometabolic Health Congress (CMHC)

2020 Update on Statin Therapy in ASCVD: Why Does Residual Risk Occur in Clinical Practice? Can the Big Data Asist in Identifying Patients With SASEs? Why Are System-Level Interventions Needed?

FEATURING Salim Virani
  • 121 views
  • September 22, 2020
08:41

Cardiometabolic Health Congress (CMHC)

2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?

FEATURING Salim Virani
  • 898 views
  • September 22, 2020
  • 3
16:40

Houston Methodist DeBakey Heart and Vascular Center

Update on Inflammation & Atherosclerosis Treatment: Should All Atherosclerosis Patients Receive Aggressive Lipid-Lowering and Inflammation Inhibiting Therapy? Why Not Combine Anti-Inflammatory Therapy with PCSK9 Inhibition?

FEATURING Paul Ridker
  • 1,523 views
  • July 14, 2020
  • 9
42:25

Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How To Treat?

FEATURING Andrew Klein
  • 4,746 views
  • July 6, 2020
  • 42
13:14

Houston Methodist DeBakey Heart and Vascular Center

Prevention of MIs and Stroke: How to Screen and Stratify Risks in the Young Before They Have an Event? Should We Start an Asymptomatic Patient on Statin Therapy?

FEATURING Salim Virani, Khurram Nasir, Haider Warraich, Ron Blankstein
  • 873 views
  • July 3, 2020
  • 1
23:46

National Lipid Association

What is the Role of Statins in Viral Pandemics? Immunomodulatory and Cardioprotective Role in Lung Injury/Sepsis/Myocardial Injury

FEATURING Sudha Ravilla
  • 2,430 views
  • June 17, 2020
  • 12
13:57

American Heart & Vascular Institute

Update on Lipid Management for ASCVD Prevention: What Is New in the Cholesterol Guidelines? When to Use Statin Therapy and When Bempedoic Acid and Inclisiran? How Effective Is Icosapent Ethyl?

FEATURING Eliot Brinton
  • 3,501 views
  • June 10, 2020
  • 20
20:22

National Lipid Association

Update on Pharmacotherapy for Obesity

FEATURING Harold Bays
  • 789 views
  • March 23, 2020
  • 2

Statins

Recommended Topics:

PCSK9

All Topics: